FSD Pharma and it's subsidiaries have progress in advancing their three drug candidates (PEA, Lycid Psych. & Lucid-MS) through clinical phases. After partnering with covar pharmaceuticals and Acquiring Lucid Psycheceuticals (subsidiary of FSD pharma Inc.), HUGE was able to recently purchase a new facility in Cobourg Ontario (CAD $17 million) which will be closing of May 31st. Should be a break soon to come after sell off.
評論:
Sale finalized of Cobourg Facility
評論:
As we near phase one of Clinicals we are seeing improvement, and by that I mean a stop in the sell of momentum we've been seeing in this security for quite some time.
Stock price has been consistent in a sideways channel for the majority of the year .
Stock price has been consistent in a sideways channel for the majority of the year .